Sugar: The Bitter Truth and the Fructose Argument

Editorial Note — Freedom of Research and the Right to Be Heard. This page documents the research, writings, and claims of Dr. Robert H. Lustig, the American pediatric endocrinologist at the University of California, San Francisco, known for his work on fructose, sugar and processed food, in the spirit of open scientific inquiry. The First Amendment’s protection of speech, and the long American tradition of medical dissent that runs from Semmelweis to Barry Marshall to Linus Pauling, exists precisely so that minority and unpopular research can be examined on its merits rather than silenced by institutional consensus. We present his facts and claims as he stated them, attributed to him, drawn from his papers, books and lectures. Readers are presumed to be intelligent adults capable of weighing evidence, consulting their own physicians, and making informed decisions about their own bodies. This page is provided for educational and historical-record purposes; it is not medical advice and does not endorse self-treatment. Censorship of a researcher is not refutation of the research. — MyHealthcare.com

Dr. Robert H. Lustig is an American pediatric endocrinologist and neuroendocrinologist, now emeritus professor of pediatrics (endocrinology) at the University of California, San Francisco (UCSF), whose public lectures and papers made fructose — one half of table sugar — the centre of a long-running argument about obesity, fatty liver and type 2 diabetes.

This page follows that argument as he states it: the 2009 lecture “Sugar: The Bitter Truth” and its follow-up “Fat Chance: Fructose 2.0”; his account of how the liver handles fructose differently from glucose; the parallels he draws between fructose and alcohol; his view that a calorie of sugar is not the same as any other calorie; the 2012 commentary in Nature that proposed controlling added sugar like alcohol; and his later case that added sugar meets the public-health criteria for regulation. A closing section describes, neutrally, what later reviews and meta-analyses on fructose reported.

The 2009 Lecture
Fat Chance: Fructose 2.0
How He Separates Glucose from Fructose
What He Says Happens in the Liver
Alcohol Without the Buzz
Why He Says a Calorie Is Not a Calorie
The Toxic Truth About Sugar (Nature, 2012)
Four Criteria for Regulation
Later Research on Fructose
Key Research Papers
Connections

1. The 2009 Lecture

“Sugar: The Bitter Truth” was recorded on May 26, 2009, at the UCSF Osher Center for Integrative Medicine as part of the university’s “Mini Medical School for the Public” series, in which UCSF faculty explain their fields to a general audience. The recording was posted to YouTube the same year and went on to collect millions of views, which made Lustig, until then known mainly to other endocrinologists, one of the best-known voices in the public debate about sugar. The original upload sits on the University of California Television channel.

His own site sums up the lecture in one sentence: “fructose (too much) and fiber (not enough) appear to be cornerstones of the obesity epidemic through their effects on insulin.” The thread through the talk is that the rise of obesity is driven less by how much people choose to eat than by what the food supply now contains, and by what that food does to insulin.

The lecture grew out of his clinical work. Lustig has described how his years caring for children whose hypothalamus had been damaged by brain tumours led him to a “unifying hypothesis” about the obesity epidemic, and from there to “the specific role of fructose (half of sucrose and high-fructose corn syrup) as a specific mediator of both chronic disease, and continued caloric consumption.” That clinical story has its own page: Hypothalamic Obesity and Insulin.

In the same year as the lecture he was a co-author of the American Heart Association’s 2009 scientific statement on dietary sugars and cardiovascular health. That statement set upper limits for added sugar which his site quotes as about 6 teaspoons (25 grams) a day for women and 9 teaspoons (38 grams) a day for men.

Back to Table of Contents

2. Fat Chance: Fructose 2.0

Lustig returned to the same series in 2013 with a follow-up lecture, “Fat Chance: Fructose 2.0”. The title echoes his book Fat Chance: Beating the Odds Against Sugar, Processed Food, Obesity, and Disease, which carried the lecture’s argument to book length. In the introduction the host noted how widely the 2009 talk had travelled, and that Lustig had since taken a sabbatical to earn a Master of Studies in Law (MSL) so that he could work on food policy as well as on biochemistry.

Between the two lectures he had put the argument into print: the paper on parallels between fructose and alcohol (Section 5), the Nature commentary on regulating added sugar (Section 7), and a population study linking sugar availability to diabetes (Section 6). A transcript of the 2013 talk is posted on his own site.

In 2013 he also published a short e-book, Sugar Has 56 Names: A Shopper’s Guide, built on the point that added sugar appears on ingredient lists under many different names. His books and their place in his career are covered on Robert Lustig: Life and Career and Metabolical and Lustig’s Case Against Processed Food.

Back to Table of Contents

3. How He Separates Glucose from Fructose

Table sugar (sucrose) is one molecule of glucose joined to one molecule of fructose; high-fructose corn syrup is a similar mixture of the two. Lustig’s argument depends on treating these two halves as different substances rather than as interchangeable “sugar”.

In his 2013 review “Fructose: it’s ‘alcohol without the buzz’” he sets out the contrast. Glucose, he writes, is the building block of starch, raises insulin, and is “not particularly sweet”. Fructose “does not generate an insulin response, and is very sweet”. He notes that sugar has long been treated as “empty calories” — energy with no nutrients attached — and argues that this description misses the point, because “fructose is unlike glucose” in what it does once it reaches the body.

The difference he emphasises is what the liver does with fructose. When fructose arrives in what he calls the “hypercaloric glycogen-replete state” — when a person is already eating more energy than they burn and the liver’s sugar stores are full — the liver has to do something else with it. Section 4 follows what he says that something else is.

The other half of his lecture summary is fibre: too much fructose and “not enough” fibre, both acting through insulin. The site’s page on Dietary Fiber covers fibre in more detail.

Back to Table of Contents

4. What He Says Happens in the Liver

Lustig’s 2013 review describes a chain of events. In the overfed state, he writes, fructose metabolites “overwhelm hepatic mitochondrial capacity” — the liver cells’ energy factories cannot keep up. The surplus is pushed into de novo lipogenesis, the liver’s process of building new fat from sugar. He links that new fat to three consequences:

Fat in the liver. Fat built in the liver can stay there, the pattern known as non-alcoholic fatty liver disease (NAFLD).
Hepatic insulin resistance. A fatty liver responds less to insulin, so the pancreas releases more insulin to get the same effect. In his model that extra insulin is what drives further weight gain.
Oxidative stress and the brain’s reward system. He lists the formation of reactive oxygen species (unstable molecules that damage cells) and changes in the brain’s reward pathways among the effects of excess fructose.

His group set out the liver side of the argument at length in a 2010 review in Nature Reviews Gastroenterology & Hepatology on the role of fructose in the development of non-alcoholic fatty liver disease and the metabolic syndrome. The metabolic syndrome is the cluster of abdominal obesity, high blood pressure, high triglycerides, low high-density lipoprotein (HDL) cholesterol and raised blood sugar. Two years later, with Alison Bremer and Michele Mietus-Snyder, he published “Toward a unifying hypothesis of metabolic syndrome” in Pediatrics, which places the liver’s handling of excess fructose near the centre of that cluster.

The chain also runs into his clinical research. A nine-day trial in children, in which sugar was swapped for starch while calories were held steady, measured liver fat and de novo lipogenesis directly; its design and results are described on Fructose Restriction Studies in Children. The site’s general pages on Non-Alcoholic Fatty Liver Disease, Insulin Resistance and Metabolic Syndrome cover each condition on its own.

Back to Table of Contents

5. Alcohol Without the Buzz

The comparison Lustig is best known for is between fructose and ethanol, the alcohol in drinks. He developed it in a 2010 paper in the Journal of the American Dietetic Association, “Fructose: metabolic, hedonic, and societal parallels with ethanol”, and gave it its short form in the 2013 review: fructose is “alcohol without the buzz”. The “without the buzz” part, he explains, is because fructose, unlike ethanol, is not metabolised in the brain, so it does not intoxicate.

The 2010 paper lists the parallels in three groups:

Metabolic. Both fructose and ethanol are used by the liver as raw material for de novo lipogenesis, and he links both to insulin resistance, abnormal blood fats (dyslipidaemia) and fatty liver. He also compares the fructosylation of proteins — fructose attaching itself to proteins, with superoxide (a reactive oxygen molecule) formed in the process — to the protein damage caused by acetaldehyde, the first breakdown product of alcohol.
Hedonic. He writes that fructose stimulates the brain’s “hedonic pathway” — the pleasure and reward circuitry — creating habituation and “possibly dependence”. His later work on reward and food addiction is covered on The Hacking of the American Mind.
Societal. Both, he argues, are treated by society as commodities.

The societal parallel is the bridge to his policy work: the 2012 Nature commentary in Section 7 proposed controlling added sweeteners in the way alcohol is controlled.

Back to Table of Contents

6. Why He Says a Calorie Is Not a Calorie

The standard explanation of weight gain is energy balance: eat more calories than you burn and the surplus is stored as fat. Lustig does not dispute the arithmetic, but in a 2006 paper in Nature Clinical Practice Endocrinology & Metabolism, “Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics”, he argues that the arrow of cause runs the other way. The behaviours of eating more and moving less, he writes, “are secondary to obligate weight gain” — they follow from a hormonal state rather than causing it. The hormone he places at the centre is insulin: high insulin levels push energy into fat cells, interfere with the signal from leptin (the hormone that tells the brain the body has enough stored energy), and blunt the fading of food reward that normally ends a meal.

From this he concludes that the source of a calorie matters, because fructose and glucose produce different hormonal and liver responses (Sections 3 and 4). He makes the point with two very different eating patterns. In his 2013 review he observes that the Atkins diet, which is low in carbohydrate, and the traditional Japanese diet, which is high in carbohydrate, both remove fructose — the feature he sees the two patterns sharing despite their opposite carbohydrate content.

He has applied the same reasoning to diabetes. In a 2016 debate piece in the Canadian Journal of Diabetes titled “Sickeningly sweet: does sugar cause type 2 diabetes? Yes”, he argued the affirmative side. The population evidence he points to most often is a 2013 econometric study he co-authored with Sanjay Basu and colleagues in PLoS One. Across 175 countries, each additional 150 kilocalories per person per day of sugar availability — about one can of soda — was associated with a 1.1% higher prevalence of diabetes, an association the authors report as independent of obesity and of total calories available.

That study is observational: it links national sugar supply to national diabetes rates and cannot show what happened to any individual. The site’s animation Blood Sugar and Insulin shows the insulin side of the story in motion.

Back to Table of Contents

7. The Toxic Truth About Sugar (Nature, 2012)

On February 1, 2012, Nature published a commentary by Lustig with two UCSF colleagues, Laura A. Schmidt and Claire D. Brindis, under the title “The toxic truth about sugar”. Its standfirst states the thesis in one line: added sweeteners “pose dangers to health that justify controlling them like alcohol”.

The authors grounded the comparison in the criteria public-health scholars use to decide when a substance is regulated. As quoted from the article, they wrote that sugar consumption “has tripled over the last 50 years”, and argued under three headings:

“Sugars have the potential for abuse”
“Sugars have negative effects on society”
“Too much of a good thing can be toxic”

They then listed the tools already used for alcohol and tobacco and proposed them for added sugar: taxes; controls on distribution; age limits; removing sugary products from schools; licensing; zoning rules on where such products can be sold; limits on television advertising; labelling of added sugars; and removing fructose from the US list of substances “generally recognised as safe” (generally recognized as safe, GRAS), the status that lets an ingredient be added to food without a separate approval.

In his 2020 paper (Section 8) Lustig points to sugar taxes adopted in several countries as steps of the kind the article proposed. One well-studied case is Mexico’s excise tax on sugar-sweetened beverages, whose effect on store purchases was reported in the BMJ in 2016.

Back to Table of Contents

8. Four Criteria for Regulation

Lustig restated the regulatory case in a formal paper in 2020, “Ultraprocessed food: addictive, toxic, and ready for regulation”, published in Nutrients. There he argues that added sugar, and by proxy ultra-processed food, meets “the four criteria set by the public health community as necessary and sufficient for regulation—abuse, toxicity, ubiquity, and externalities”. In plain terms:

Abuse — people eat it in ways that resemble the use of other habit-forming substances.
Toxicity — in his view it does harm beyond its calories, through the liver mechanisms in Section 4.
Ubiquity — it is so widespread in the food supply that individuals find it hard to steer clear of.
Externalities — the costs of the resulting disease fall on everyone, through health systems and lost work, not only on the person eating.

In the same paper he writes that public education about sugar has been ineffective, “in part due to food industry interference”, and cites the sugar taxes some countries have adopted as steps in the direction he favours. A UCSF modelling study he co-authored in BMJ Open in 2017 estimated the health and economic effects of reducing sugar intake in the United States, including effects that would run through non-alcoholic fatty liver disease.

His personal bottom line is blunter than any of his papers. On his own website he asks how much added sugar a person needs to maintain optimal health and answers: “ZERO. ZIP. NADA. BUPKIS.” That is his position as he states it. For comparison, the American Heart Association statement he co-authored in 2009 set upper limits rather than zero (Section 1). His wider argument against processed food is followed on Metabolical and Lustig’s Case Against Processed Food, and the site’s page on Ultra-Processed Foods covers the subject more broadly.

Back to Table of Contents

9. Later Research on Fructose

Fructose became one of the most studied sugars in nutrition science in the years around and after the lecture. The papers below are described as later research on the same subject; each reached its own conclusions.

Fructose versus glucose drinks (2009). Kimber Stanhope and colleagues reported in the Journal of Clinical Investigation a randomised trial in overweight and obese adults in which drinks sweetened with fructose, but not drinks sweetened with glucose, increased visceral (deep abdominal) fat and blood lipids and decreased insulin sensitivity.
Standard review of fructose metabolism (2010). Luc Tappy and Kim-Anne Lê reviewed the metabolic effects of fructose and the worldwide rise in obesity in Physiological Reviews.
Sugar-sweetened beverages (2010). A meta-analysis led by Vasanti Malik in Diabetes Care examined sugar-sweetened beverages and the risk of metabolic syndrome and type 2 diabetes.
Fructose and body weight in feeding trials (2012). A systematic review and meta-analysis led by John Sievenpiper in the Annals of Internal Medicine pooled controlled feeding trials. In trials where fructose replaced other carbohydrate at the same calorie level, it did not find a fructose-specific effect on body weight; weight gain appeared in trials where fructose added extra calories.
Dietary sugars and body weight (2012). Lisa Te Morenga and colleagues published in the BMJ a systematic review and meta-analyses of randomised trials and cohort studies on dietary sugars and body weight.
Fructose and fatty liver markers (2014). A meta-analysis of controlled feeding trials led by Sanjay Chiu in the European Journal of Clinical Nutrition reported a similar pattern for markers of non-alcoholic fatty liver disease: no fructose-specific effect when calories were matched, with effects seen when fructose supplied extra energy.
Two reviews of the debate (2014). A review by Vincent van Buul, Luc Tappy and Fred Brouns in Nutrition Research Reviews argued that several common beliefs about fructose-containing sugars and obesity are misconceptions. In Diabetes Care the same year, Richard Kahn and John Sievenpiper took the opposing side of a published debate on sugar and body weight, attributing the harm to excess calories rather than to sugar as such.
Fructose and cardiometabolic health (2015). Vasanti Malik and Frank Hu reviewed in the Journal of the American College of Cardiology what the evidence from sugar-sweetened beverages shows about fructose and heart and metabolic health.
“The state of the controversy” (2016). Kimber Stanhope reviewed the debate over sugar consumption, metabolic disease and obesity under that subtitle in Critical Reviews in Clinical Laboratory Sciences.
Fructose and fatty liver (2018). Thomas Jensen and colleagues reviewed fructose and sugar as a major mediator of non-alcoholic fatty liver disease in the Journal of Hepatology.

A central question running through these papers is the one Lustig’s own trial set out to address: whether fructose does harm at the same calorie level as other carbohydrates, or only when it adds calories. His nine-day trial in children, and the published exchange about weight change in that trial, are described on Fructose Restriction Studies in Children. The site’s page on Added Sugar and Weight covers the wider evidence on sugar and body weight.

Back to Table of Contents

Key Research Papers

Lustig RH. Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics. Nat Clin Pract Endocrinol Metab. 2006;2(8):447-58. — PubMed PMID: 16932334
Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120(11):1011-20. — PubMed PMID: 19704096
Lustig RH. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc. 2010;110(9):1307-21. — PubMed PMID: 20800122
Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7(5):251-64. — PubMed PMID: 20368739
Lustig RH, Schmidt LA, Brindis CD. Public health: The toxic truth about sugar. Nature. 2012;482(7383):27-9. — PubMed PMID: 22297952
Bremer AA, Mietus-Snyder M, Lustig RH. Toward a unifying hypothesis of metabolic syndrome. Pediatrics. 2012;129(3):557-70. — PubMed PMID: 22351884
Lustig RH. Fructose: it’s “alcohol without the buzz”. Adv Nutr. 2013;4(2):226-35. — PubMed PMID: 23493539
Basu S, Yoffe P, Hills N, Lustig RH. The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS One. 2013;8(2):e57873. — PubMed PMID: 23460912
Lustig RH. Sickeningly Sweet: Does Sugar Cause Type 2 Diabetes? Yes. Can J Diabetes. 2016;40(4):282-6. — PubMed PMID: 27216628
Vreman RA, Goodell AJ, Rodriguez LA, Porco TC, Lustig RH, Kahn JG. Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model. BMJ Open. 2017;7(8):e013543. — PubMed PMID: 28775179
Lustig RH. Ultraprocessed Food: Addictive, Toxic, and Ready for Regulation. Nutrients. 2020;12(11):3401. — PubMed PMID: 33167515
Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322-34. — PubMed PMID: 19381015
Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90(1):23-46. — PubMed PMID: 20086073
Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010;33(11):2477-83. — PubMed PMID: 20693348
Sievenpiper JL, de Souza RJ, Mirrahimi A, Yu ME, Carleton AJ, Beyene J, et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med. 2012;156(4):291-304. — PubMed PMID: 22351714
Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ. 2012;346:e7492. — PubMed PMID: 23321486
Chiu S, Sievenpiper JL, de Souza RJ, Cozma AI, Mirrahimi A, Carleton AJ, et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2014;68(4):416-23. — PubMed PMID: 24569542
van Buul VJ, Tappy L, Brouns FJ. Misconceptions about fructose-containing sugars and their role in the obesity epidemic. Nutr Res Rev. 2014;27(1):119-30. — PubMed PMID: 24666553
Kahn R, Sievenpiper JL. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: we have, but the pox on sugar is overwrought and overworked. Diabetes Care. 2014;37(4):957-62. — PubMed PMID: 24652726
Malik VS, Hu FB. Fructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us. J Am Coll Cardiol. 2015;66(14):1615-1624. — PubMed PMID: 26429086
Stanhope KL. Sugar consumption, metabolic disease and obesity: The state of the controversy. Crit Rev Clin Lab Sci. 2016;53(1):52-67. — PubMed PMID: 26376619
Colchero MA, Popkin BM, Rivera JA, Ng SW. Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study. BMJ. 2016;352:h6704. — PubMed PMID: 26738745
Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):1063-1075. — PubMed PMID: 29408694

Sugar: The Bitter Truth and the Fructose Argument

Table of Contents

1. The 2009 Lecture

2. Fat Chance: Fructose 2.0

3. How He Separates Glucose from Fructose

4. What He Says Happens in the Liver

5. Alcohol Without the Buzz

6. Why He Says a Calorie Is Not a Calorie

7. The Toxic Truth About Sugar (Nature, 2012)

8. Four Criteria for Regulation

9. Later Research on Fructose

Key Research Papers

PubMed Topic Searches

Further Reading

Connections